NCT00236418View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 1994

Study Completion Date

December 31, 1996

Conditions
EpilepsySeizures
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236418 - A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures | Biotech Hunter | Biotech Hunter